European Archives - Page 843 of 1213 - European Medical Journal

"We need to move from the idea people have today – that digital just enables you to do things slightly better – to looking at the potential of doing completely new things"

Ameet Nathwani is Chief Medical Officer and Executive Vice President at Sanofi. As a person well known for his interest and work in the use of new technologies in healthcare, he spoke to us about the changes these innovations are making to the pharmaceutical industry and the potential they have to transform the way patients are treated in the future.

The Gut and Cow’s Milk Allergy

MICROBES in the gut may offer the potential to prevent cow’s milk allergy from developing in infants…

Unlocking the Potential of Immuno-Oncology in Advanced Cutaneous Squamous Cell Carcinoma: Role of Checkpoint Blockade

The rising incidence of CSCC presents a major challenge for healthcare systems and the frequency and impact of progression to advanced disease is…

EMJ Dermatology 6 [Suppl 1] 2019

Dr Robert welcomed the delegates to the symposium and outlined the agenda for the meeting, before presenting the first session on understanding cutaneous…

Histamine-Boosting Drugs: Innovation in the Treatment of Impaired Memory

HISTAMINE is perhaps best known for its role in allergic reactions; however, this compound has many more functions within the body…

The Legacy of Sheila Sherlock in Hepatology

Sheila Sherlock’s impact on the field of hepatology is felt throughout the world, having been at the heart of pioneering research discoveries and the…

An Interview with Heather Moses from Roche

An interview with Heather Moses, Head of Medical Affairs, Roche Products Ltd. We met with Heather at the Roche Hub, Welwyn Garden City, where Heather provided insight on the current and evolving landscape of Medical Affairs, as well as a personal perspective on senior leadership within the life-sciences industry.

Cannabis Use Impacts Sperm Health

LEGALISATION of cannabis use in various states within the USA has seen the substance thrown into the national spotlight; however, the impact the drug…

New Risk Factors Identified for Childhood Asthma

PREVENTING childhood asthma is one of the leading goals of respiratory medicine and modifiable risk factors are highly prized.

"We Want to Cover an Entire Therapeutic Spectrum, Helping Patients to Become Owners of their Conditions Alongside Dermatologists"

Alfredo Barón de Juan is Executive Vice President of Global Commercial Operations and Chief Commercial Officer of the Spanish-based pharmaceutical company Almirall. In a recent interview, we discussed a range of topics, such the importance of company values to the success of Almirall and the growth of partnerships and collaboration in the pharma industry.